28-09-2024 | Genetic Testing | ASO Author Reflections
ASO Author Reflections: Mainstream Genetic Testing Makes It Feasible for a Large Integrated System to Expand the Testing Eligibility in Breast Cancer
Authors:
Veronica Shim, MD, Audrey Karlea, MS, LCGC, Laurel Habel, PhD
Published in:
Annals of Surgical Oncology
|
Issue 1/2025
Login to get access
Excerpt
The guidelines for multigene panel germline testing for hereditary cancer in patient with early breast cancer have continued to change and expand eligibility recommendations. In 2019, the National Comprehensive Cancer Network recommended testing all patients diagnosed under < 45 years.
1 In early 2024, Society of Surgical Oncology/American Society of Clincial Oncology joint guidelines recommended universal genetic testing for patients with breast cancer ≤ 65 years.
2 …